3rd International Conference on Modern Warfare, Human Rights, and International Law | IMS Unison University

School of Law at IMS Unison University, Dehradun is organizing its 3rd International Conference on Modern Warfare, Human Rights, and International Law: Challenges and Responses, scheduled to be held from May 23-24, 2025. About the Institution The School of Law at IMS Unison University, Dehradun, is a premier institution dedicated to shaping skilled and ethical

... Continue Reading.

Updated Master Direction On Foreign Investment In India: Clarifications To The Regulatory Framework

Updated Master Direction On Foreign Investment In India: Clarifications To The Regulatory Framework BACKGROUND The Reserve Bank of India (“RBI”) recently updated the Master Direction on Foreign Investment in India (“Master Direction”) to address various ambiguities in the regulatory framework for downstream investments by foreign owned or controlled companies (“FOCCs”), cross-border share swaps, and issue

... Continue Reading.

Day 1 Highlights: National Conference on Navigating Legal Frontiers in India: Recent Trends at Law Centre II, University of Delhi

New Delhi, April 3, 2025 — The prestigious Law Centre II, Faculty of Law, University of Delhi commenced its much-awaited National Conference on “Navigating Legal Frontiers in India: Recent Trends” today with a grand Inaugural Ceremony held at the Moot Court Hall, Umang Bhawan. The event witnessed the esteemed presence of Hon’ble Mr. Justice Sanjay

... Continue Reading.

Craig Stanfield Joins Paul Hastings As Partner To Strengthen Litigation Practice In Houston

Craig Stanfield Joins Paul Hastings As Partner To Strengthen Litigation Practice In Houston Paul Hastings LLP has announced the addition of first-chair trial lawyer Craig Stanfield as a partner in its Houston office, reinforcing the firm’s leading litigation practice and expanding its presence in Texas. Stanfield brings extensive trial experience in high-stakes litigation across federal

... Continue Reading.

Paul Hastings Advised Financing Sources On Cotiviti’s Acquisition Of Edifecs

Paul Hastings Advised Financing Sources On Cotiviti’s Acquisition Of Edifecs Paul Hastings LLP advised the financing sources in Cotiviti’s acquisition of Edifecs, a pioneer in healthcare data interoperability. Cotiviti, a portfolio company of Veritas Capital and KKR, continues its strategic expansion with this acquisition. Paul Hastings previously advised the lead arrangers on $5.6 billion of

... Continue Reading.

[Part III] Should Delhi High Court be Inviting Pharmaceutical Companies for its Official Event to Mark World IP Day?

After two hard-hitting posts (Part I and Part II) on transparency surrounding public money in COVID-19 vaccines, Prashant Reddy wraps up this three part saga with a curious incident. Here, he writes on the DHC’s move to invite Bharath Biotech’s executive as a guest to its official event marking World IP Day, 2023. In this

... Continue Reading.

[Part II] Public Money, Private Patents? Unravelling India’s Opacity over its COVID Vaccines

Continuing the discussion on opacity behind the public money invested in development of COVID-19 vaccines, Prashant Reddy T, in Part II of his post, recounts his struggle with the government, including his eventual litigation to access essential public documents related to government funding in the vaccines. Please Note: This part includes some sections from Part I

... Continue Reading.

Shardul Amarchand Mangaldas & Co. Appoints Nishant Singh, Ranjana Adhikari, And Mihir Prashant Deshmukh as Partners

Shardul Amarchand Mangaldas & Co. Appoints Nishant Singh, Ranjana Adhikari, and Mihir Prashant Deshmukh as Partners Shardul Amarchand Mangaldas & Co. (SAM & Co.) has strengthened its General Corporate and Tax practice groups with the appointment of Nishant Singh, Ranjana Adhikari, and Mihir Prashant Deshmukh as Partners in Mumbai. This expansion underscores the firm’s commitment

... Continue Reading.

[Part I] India’s Hypocrisy over the TRIPs Waiver During the Pandemic

In a series of three hard-hitting posts, Prashant Reddy T exposes the alarming lack of transparency surrounding public funds spent on indigenously developed COVID-19 vaccines. He details his ordeal in attempting to obtain crucial information from the government and raises pressing concerns about the absence of accountability in public spending. Part I highlights the government’s

... Continue Reading.